Home Other Building Blocks Bismuth Subsalicylate

Bismuth Subsalicylate

CAS No.:
14882-18-9
Catalog Number:
AG001L84
Molecular Formula:
C7H5BiO4
Molecular Weight:
362.0926
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
25mg
99.9%
In Stock USA
United States
$57
- +
100mg
99.9%
In Stock USA
United States
$115
- +
Product Description
Catalog Number:
AG001L84
Chemical Name:
Bismuth Subsalicylate
CAS Number:
14882-18-9
Molecular Formula:
C7H5BiO4
Molecular Weight:
362.0926
MDL Number:
MFCD00085368
IUPAC Name:
1,3,2λ2-benzodioxabismin-4-one;hydrate
InChI:
InChI=1S/C7H6O3.Bi.H2O/c8-6-4-2-1-3-5(6)7(9)10;;/h1-4,8H,(H,9,10);;1H2/q;+2;/p-2
InChI Key:
QBWLKDFBINPHFT-UHFFFAOYSA-L
SMILES:
O[Bi]1OC(=O)c2c(O1)cccc2
EC Number:
238-953-1
NSC Number:
759117
Properties
Complexity:
173  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
363.007g/mol
Formal Charge:
0
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
363.101g/mol
Monoisotopic Mass:
363.007g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
36.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20120201
Mechanosynthesis of the metallodrug bismuth subsalicylate from Bi2O3 and structure of bismuth salicylate without auxiliary organic ligands. Angewandte Chemie (International ed. in English) 20110816
Diagnosis and treatment of Helicobacter pylori infection. Danish medical bulletin 20110401
Helicobacter pylori infection. The New England journal of medicine 20100805
Crohn's colitis with perianal disease complicated by collagenous colitis: discourse on management options. Digestion 20100101
Mucosal tear in collagenous colitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20090901
Fluorescence in situ hybridization confirms clearance of visible Helicobacter spp. associated with gastritis in dogs and cats. Journal of veterinary internal medicine 20090101
Expert review of the evidence base for self-therapy of travelers' diarrhea. Journal of travel medicine 20090101
[Topic: Treating travelers' diarrhea. When should medication be given?]. Der Urologe. Ausg. A 20080601
Interventions for treating lymphocytic colitis. The Cochrane database of systematic reviews 20080416
[Treating travelers' diarrhea. When should medication be given?]. Der Internist 20071201
Effect of smoking on failure of H. pylori therapy and gastric histology in a high gastric cancer risk area of Colombia. Acta gastroenterologica Latinoamericana 20071201
Cooperative influence of thiolate ligands on the bio-relevant coordination chemistry of bismuth. Journal of inorganic biochemistry 20070401
Pharmacotherapy for microscopic colitis. Pharmacotherapy 20070301
Helicobacter pylori infection and thrombocytopenia: a single-institution experience in Mexico. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20070101
Triple antimicrobial therapy and acid suppression in dogs with chronic vomiting and gastric Helicobacter spp. Journal of veterinary internal medicine 20070101
Efficacy of two triple eradication regimens in children with Helicobacter pylori infection. Journal of Korean medical science 20061201
Current and future developments in travelers' diarrhea therapy. Expert review of anti-infective therapy 20060601
Salicylate toxicity associated with administration of Percy medicine in an infant. Pharmacotherapy 20060301
[Plant sulfate assimilation and regulation of the activity of related enzymes under cadmium stress]. Zhi wu sheng li yu fen zi sheng wu xue xue bao = Journal of plant physiology and molecular biology 20060201
Travellers' diarrhoea: contemporary approaches to therapy and prevention. Drugs 20060101
Copolymerizations of epsilon-caprolactone and glycolide-a comparison of tin(II)octanoate and bismuth(III)subsalicylate as initiators. Biomacromolecules 20050101
Eradication of Helicobacter pylori can be accurately confirmed 14 days after termination of triple therapy using a high-dose citric acid-based 13C urea breath test. Digestion 20050101
Interventions for treating collagenous colitis: a Cochrane Inflammatory Bowel Disease Group systematic review of randomized trials. The American journal of gastroenterology 20041201
Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20040601
Diagnosis and management of microscopic colitis syndrome. Journal of clinical gastroenterology 20040101
One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection. Archives of internal medicine 20030922
[Treatment of collagenous colitis. An analysis of a systematic Cochrane review]. Ugeskrift for laeger 20030811
Increased reflux symptoms after calcium carbonate supplementation and successful anti-Helicobacter pylori treatment. Digestive diseases and sciences 20030801
Lymphocytic and collagenous colitis: the emerging entity of microscopic colitis. An update on pathophysiology, diagnosis and management. Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20030701
Interventions for treating collagenous colitis. The Cochrane database of systematic reviews 20030101
Towards a molecular model for bismuth(III) subsalicylate. Synthesis and solid-state structure of [Bi(Hsal)3(bipy)(C7H8]2 and [Bi(Hsal)(sal)(1,10-phenanthroline)(C7H8]2. Chemical communications (Cambridge, England) 20021207
Helicobacter pylori infection. The New England journal of medicine 20021010
[Classic triple therapy for Helicobacter pylori infection]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Treatment of gastritis-associated Helicobacter pylori infection in children]. Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20020101
Interventions for treating collagenous colitis. The Cochrane database of systematic reviews 20020101
Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage. Alimentary pharmacology & therapeutics 20011201
Anti-inflammatory and tissue-protectant drug effects: results from a randomized placebo-controlled trial of gastritis patients at high risk for gastric cancer. Alimentary pharmacology & therapeutics 20010601
Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance. Alimentary pharmacology & therapeutics 20010401
[Common gastrointestinal symptoms and their effective and safe treatment]. Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 19990501
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial. The American journal of gastroenterology 19970901
Bismuth subsalicylate prophylaxis of Cryptosporidium parvum infection in immunodeficient mice. The Journal of eukaryotic microbiology 19960101
Protective effect of Pepto-Bismol liquid on the gastric mucosa of rats. Gastroenterology 19750901
Properties